| Gene |
[FAM172A](/genes/fam172a) |
| UniProt |
Q9H6X5 |
| Molecular Weight |
37 kDa |
| Subcellular Localization |
Predominantly cytoplasmic |
| Protein Family |
FAM172 family |
| Tissue Expression |
Broad, highest in brain and testis |
FAM172A (Family With Sequence Similarity 172 Member A) is a relatively uncharacterized protein that has garnered interest in neurodegeneration research due to its genetic associations with Alzheimer's disease and Parkinson's disease. While the precise biological functions of FAM172A remain under investigation, studies suggest it may play roles in cellular metabolism, protein quality control, and neuronal survival.
¶ Structure and Evolution
FAM172A is a relatively small protein of approximately 326 amino acids with the following structural features:
- N-terminal domain: Contains predicted coiled-coil regions that may mediate protein-protein interactions
- Central region: Low-complexity sequences with potential regulatory functions
- C-terminal domain: Highly conserved across species, suggesting functional importance
The protein is conserved from mammals to fish, indicating an evolutionarily important function.
FAM172A demonstrates broad tissue expression with notable highlights in:
- Central nervous system: Expressed in various brain regions including the hippocampus, cerebral cortex, and cerebellum
- Peripheral tissues: Highest expression in testis, with moderate levels in liver, kidney, and heart
- Cellular localization: Primarily cytoplasmic, with some nuclear localization reported
FAM172A has been implicated in Alzheimer's disease through multiple lines of evidence:
- Genetic associations: Genome-wide association studies (GWAS) have identified FAM172A variants associated with late-onset AD risk
- Amyloid-beta metabolism: Preliminary studies suggest FAM172A may interact with proteins involved in amyloid precursor protein (APP) processing
- Tau pathology: Some evidence links FAM172A to tau phosphorylation pathways
In Parkinson's disease research, FAM172A has been studied for its potential role in:
- Alpha-synuclein dynamics: May influence alpha-synuclein aggregation and clearance
- Mitochondrial function: FAM172A localizes to mitochondria in neurons and may affect mitochondrial quality control
- Lysosomal function: Possible involvement in lysosomal pathways relevant to PD pathogenesis
FAM172A appears to affect neuronal survival through several mechanisms:
- Protein quality control: May play a role in the ubiquitin-proteasome system and autophagy
- Cellular stress response: Involved in responses to oxidative stress and ER stress
- Calcium homeostasis: Some studies suggest FAM172A affects calcium signaling in neurons
- Apoptosis regulation: May modulate pro-apoptotic and anti-apoptotic pathways
FAM172A has been investigated as a potential biomarker for neurodegenerative diseases:
- Cerebrospinal fluid (CSF) levels: Altered FAM172A levels have been reported in AD and PD patients
- Blood-based markers: Peripheral blood mononuclear cell expression changes have been observed
While FAM172A is not currently a validated drug target, several approaches could be explored:
- Small molecule modulators: Compounds that enhance or inhibit FAM172A function
- Gene therapy approaches: Viral vector-mediated FAM172A modulation
- Protein replacement: For deficiency states
FAM172A remains a relatively understudied protein, presenting challenges for drug development:
- Limited functional characterization: The normal physiological roles of FAM172A are not fully understood
- Unknown structure: Crystal structure determination would aid drug design
- Conflicting findings: Some genetic association studies have not replicated